COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer (NeoFox)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03883802
Recruitment Status : Recruiting
First Posted : March 21, 2019
Last Update Posted : April 25, 2019
SMS-Oncology BV
SAGA diagnostics AB
Unilabs A/S
BioVica AB
Catalan Institute of Oncology
Information provided by (Responsible Party):
WntResearch AB

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 14, 2022
Estimated Study Completion Date : March 14, 2022